| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |